Effect of TYB-2285 on lung anaphylaxis in actively sensitized rats. 1997

A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
Department of Pharmacology, Toyobo Co. Ltd., Shiga, Japan.

1. We examined the effect of TYB-2285 on the acute phase and the late phase of lung anaphylaxis in rats. 2. TYB-2285 (3-30 mg/kg PO) inhibited antigen-induced bronchoconstriction and TxB2 production during the acute phase of lung anaphylaxis in a dose-dependent manner. 3. Ketotifen fumarate (30 mg/kg p.o.) inhibited bronchoconstriction and TxB2 production less potently than TYB-2285. 4. TYB-2285 (30 mg/kg p.o.) inhibited the accumulation of neutrophils during the late phase of lung anaphylaxis significantly without a significant change in total cells. 5. Hydrocortisone acetate (100 mg/kg p.o.) inhibited the accumulation of total cells as potent as neutrophils.

UI MeSH Term Description Entries
D007665 Ketotifen A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis. 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one,Ketotifen Fumarate,Ketotifene,Ketotiphen,Ketotiphene,Zaditen,Fumarate, Ketotifen
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
August 1998, General pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
November 1994, The Journal of pharmacy and pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
March 1997, General pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
February 1996, Pulmonary pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
July 1984, Acta pharmacologica et toxicologica,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
January 1993, Voprosy pitaniia,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
April 1986, Allergy,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
March 1992, European journal of pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
May 1982, British journal of pharmacology,
A Watanabe, and T Tominaga, and H Shutoh, and H Hayashi, and J Tsuji, and A Koda, and H Nagai, and Y Kumazawa, and H Shimada
November 1987, Allergy,
Copied contents to your clipboard!